Rwanda Begins Africa's First Trial of Long-Acting Malaria Prevention Injection

Rwanda has initiated the continent's first clinical trial for a long-acting injectable drug aimed at preventing malaria. This development comes amid growing concerns over drug resistance and climate change, which threaten existing malaria control efforts.

Originally published by gnews